Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006
Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
Pulmonary rehabilitation, COPD assessment test and smoking cessation at smokers with COPD Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006
Effects of one year smoking cessation on inflammation in induced sputum of smokers with and without COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002
Duration of smoking cessation and bronchial inflammation in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004
Predictors of smoking cessation during spirometric sreening for COPD Source: Eur Respir J 2001; 18: Suppl. 33, 487s Year: 2001
The impact of smoking cessation on respiratory symptoms in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 391s Year: 2005
Effects of exercise in patients with moderate to severe asthma Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007
Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007
Efficacy of confronting smokers with airflow limitation for smoking cessation Source: Eur Respir J 2009; 33: 754-762 Year: 2009
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018
Does Smoking Cessation affect symptoms and FEV1 in smokers with mild COPD? Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities Year: 2020
Influence of smoking on reversibility of obstruction in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002
Effects of mass spirometry and antismoking advice on smoking cessation in subjects with airflow limitation Source: Eur Respir J 2001; 18: Suppl. 33, 117s Year: 2001
Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006
The respiration status in smokers with chronic bronchitis during smoking cessation period Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002
Introductory lecture: Nicotine addiction treatment in COPD patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007